CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
Abstract Harnessing CRISPR-Cas9 technology for cancer therapeutics has been hampered by low editing efficiency in tumors and potential toxicity of existing delivery systems. Here, we